Dostinex
In the US, Dostinex (cabergoline systemic) is a member of the following drug classes: dopaminergic antiparkinsonism agents, prolactin inhibitors and is used to treat Hyperprolactinemia.
US matches:
UK matches:
- DOSTINEX 0.5MG TABLETS (Leaflet)
- DOSTINEX 500 MICROGRAMS TABLETS (Leaflet)
- DOSTINEX 500MCG TABLETS (Leaflet)
Ingredient matches for Dostinex
Cabergoline is reported as an ingredient of Dostinex in the following countries:
- Argentina
- Australia
- Austria
- Bahrain
- Belgium
- Belize
- Brazil
- Bulgaria
- Canada
- Chile
- Colombia
- Costa Rica
- Czech Republic
- Dominican Republic
- Ecuador
- El Salvador
- Finland
- France
- Georgia
- Germany
- Greece
- Guatemala
- Honduras
- Hong Kong
- Iceland
- Ireland
- Israel
- Italy
- Latvia
- Lithuania
- Malaysia
- Malta
- Mexico
- Netherlands
- New Zealand
- Nicaragua
- Norway
- Oman
- Panama
- Peru
- Poland
- Portugal
- Romania
- Russian Federation
- Singapore
- South Africa
- Spain
- Sweden
- Switzerland
- Taiwan
- Tunisia
- Turkey
- United Kingdom
- United States
- Venezuela
International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
